Assessment of the Number of Missing Tooth Surfaces and the Molecular Findings on the Outcomes of Vital Pulp Therapy Using Two Calcium Silicate Materials
VPT
Sponsor study identifier
interventional
60
1 country
1
Study Start
September 21, 2022
Actual (reported)Primary Completion
October 1, 2023
Actual (reported)Study Completion
May 1, 2024
Actual (reported)The present study aimed to evaluate and compare the clinical and radiographic outcomes of full pulpotomy in mandibular molar teeth with symptomatic irreversible pulpitis according to: A. Number of tooth surfaces defects:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 1, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 21, 2022
Actual (reported)October 1, 2023
Actual (reported)May 1, 2024
Actual (reported)January 16, 2025
Actual (reported)January 22, 2025
Actual (reported)success/failure
Treatment was considered successful (healed) according to Zanini et al. (2016) based on the following criteria: (Clinically) absence of signs and symptoms of pulpal pathosis, no history of spontaneous pain or discomfort on chewing, no tenderness to percussion/palpation, no soft tissue swelling, fistula, or abnormal mobility. (Radiographically) absence of periapical rarefaction (normal width of periodontal ligament space and normal appearance of the lamina dura), internal or external resorption, and absence of root canal calcification
Patients were scheduled for follow-up appointments (one week, 3, 6, and 12 months)
Pain assessment
Pre-treatment, the patients were instructed on how to fill out a visual analog scale VAS to determine their pain score. Postoperative pain was recorded by the patient every 24 hours in the evening for 7 days. The VAS included scores from 0 to 10, which were further categorized as no pain (0), mild (1-3), moderate (4-6), severe (7-9), or severe intolerable (10).
every 24 hours in the evening for 7 days
The selected patients were divided into two groups according to the number of tooth surfaces defects (n=30) (30 with class I and 30 with class II cavity defects)
Each group was randomly further subdivided using Microsoft Excel into two subgroups according to the dressing materials, without informing the patients which type of material was used (n=15).
access to dental pulp chamber under aseptic condition, collect blood sample using a micropipette for ELIZA test, stop bleeding using sodium hypochlorite 2.5%, pulpotomy dressing material over pulp stump and final restoration with resign modified glass ionomer and composite resign
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Faculty of Dentistry, Suez Canal University
Ismailia, Egypt
Dalia Mukhtar Fayyad, Professor of endodontics
Suez Canal University
60 participants (actual enrollment reported by the registry).
First Submitted
January 16, 2025
First Posted
Contact the study team to confirm eligibility.
January 22, 2025
Study Start
September 21, 2022
Actual (reported)Primary Completion
October 1, 2023
Actual (reported)Study Completion
May 1, 2024
Actual (reported)Last Updated
June 5, 2025
Record last verified: 2025-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: